March 30 (Reuters) - Bone Therapeutics SA BIOS.BR :
* BIOSENIC PUBLISHES NEW DATA ON MECHANISM OF ACTION OF
ARSENIC
TRIOXIDE (ATO)
* ANNOUNCES THAT DATA PROVIDING ADDITIONAL DETAILS ABOUT
MECHANISM
OF ACTION OF ITS LEAD API ARSENIC TRIOXIDE (ATO) TO PREVENT
AUTOIMMUNE DISEASES HAS NOW BEEN PUBLISHED IN A PEER-REVIEWED
PAPER
* ARTICLE ALSO DETAILS AN ORIGINAL ATO FORMULA TO MAXIMIZE
EFFICACY IN FIGHTING AUTOIMMUNITY AND REDUCING SIDE EFFECTS
* NEW PEER-REVIEWED ARTICLE ALSO DEMONSTRATES THAT EFFICACY
OF ATO
IS PARTLY RELATED TO GENERATION OF REACTIVE OXYGEN SPECIES (ROS)
Source text for Eikon: ID:nGNE86MgLP
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))